Encinitas, CA, United States of America

Srinivas Rao

This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Empathbio, Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Srinivas Rao. Retrieved from https://idiyas.com/inventor/srinivas-rao-d8w42wrt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Srinivas Rao in Neurological Treatments

Introduction

Srinivas Rao is an accomplished inventor based in Encinitas, CA. He has made significant contributions to the field of pharmacology, particularly in the development of prodrugs for neurological diseases. His work focuses on enhancing the therapeutic potential of existing compounds.

Latest Patents

Srinivas Rao holds a patent for "Prodrugs of MDMA, MDA, and derivatives thereof." This patent presents prodrug compounds that exhibit an improved pharmacokinetic profile, making them suitable for treating various neurological diseases. The innovation aims to optimize the efficacy and safety of these compounds in clinical applications.

Career Highlights

Rao is associated with Empathbio, Inc., where he continues to explore advancements in drug development. His expertise in pharmacokinetics and drug formulation has positioned him as a key player in the research and development of novel therapeutic agents.

Collaborations

Throughout his career, Srinivas has collaborated with notable professionals in the field, including Glenn Short and Robert B Perni. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Srinivas Rao's contributions to the field of pharmacology, particularly through his patent on prodrugs, highlight his commitment to advancing treatments for neurological diseases. His work at Empathbio, Inc. and collaborations with esteemed colleagues further underscore his impact in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…